Results 191 to 200 of about 244,608 (247)

Incidence of Circulating Antibodies Against Hemagglutinin of Influenza Viruses in Epidemic Season 2023/2024 in Poland. [PDF]

Biomolecules
Kondratiuk K, Masny A, Poznańska A, Szymański K, Łuniewska K, Czajkowska E, Mańkowski B, Brydak LB.   +7 more
europepmc   +1 more source

Immunogenicity and safety of mRNA-based seasonal influenza vaccines encoding hemagglutinin and neuraminidase. [PDF]

Nat Commun
Rudman Spergel AK, Lee IT, Koslovsky K, Schaefers K, Avanesov A, Logan DK, Hemmersmeier J, Ensz D, Stadlbauer D, Hu B, Pucci A, Vakil J, Paris R, Ananworanich J, Nachbagauer R.   +14 more
europepmc   +1 more source

Recombinant quadrivalent influenza vaccine (RIV) induces robust cell-mediated and HA-specific B cell humoral immune responses among healthcare personnel. [PDF]

Vaccine
Mishina M, Cao W, Ende Z, Sharma SS, Ray SD, Kumari R, Kumar A, Shanmugasundaram U, Bohannon CD, Ranjan P, Chang J, Carney P, Stevens J, Levine MZ, Kim S, Wesley M, Ball S, Pando MJ, Dobin S, Knight PR, Varadarajan R, Thompson M, Dawood FS, Naleway AL, Gaglani M, Gangappa S, Sambhara S.   +26 more
europepmc   +1 more source

Simvastatin Combined with CpG Enhances the Immunogenicity of the H9N2 Inactivated Vaccine. [PDF]

Vet Sci
Ma Y, Zhu J, Song Z, Jiao L, Yu R, Wang Z, Zhang Z, Liu J, Liu Z.   +8 more
europepmc   +1 more source

Chitosan-<i>graft</i>-poly(<i>N</i>-vinylcaprolactam) Nanoparticles Containing <i>Crotalus atrox</i> Snake Venom: Biological and Physicochemical Characterization. [PDF]

Nanomaterials (Basel)
Rudy SS, Jimenez-Canale J, Sarabia-Sainz JA, Guzmán Partida AM, Burgara-Estrella AJ, Silva-Campa E, Angulo Molina A, Montiel-Herrera M, Flores-Ramírez N, Zavala-Rivera P, Fernández-Quiroz D.   +10 more
europepmc   +1 more source

Enhanced and Prolonged Immunogenicity in Mice of Thermally Stabilized Fatty Acid-Conjugated Vaccine Antigen. [PDF]

Vaccines (Basel)
Kim BM, Kim YH, Ngo HV, Nguyen HD, Park C, Lee BJ.   +5 more
europepmc   +1 more source

Characterization of antigenically dominant regions in the hemagglutinin protein of B/victoria-lineage influenza B virus using monoclonal antibody escape mutants. [PDF]

Virus Res
Matsuzaki Y, Sugawara K, Kadowaki Y, Kidoguchi Y, Shimotai Y, Mizuta K.   +5 more
europepmc   +1 more source

Epitope-Specific Antibody Immunodominance Driving Antibody and Influenza Viral Evolution During 2010- 2024. [PDF]

Open Forum Infect Dis
Lu X, Liu F, Tzeng WP, Zheng XY, Tumpey TM, York IA, Kondor RJ, Levine MZ.   +7 more
europepmc   +1 more source

The Baculovirus Expression System Expresses Chimeric RHDV VLPs as Bivalent Vaccine Candidates for Classic RHDV (GI.1) and RHDV2 (GI.2). [PDF]

Vaccines (Basel)
Wang Y, Fan Y, Bi R, Zhao Y, Gao W, Zhang D, Bai J.   +6 more
europepmc   +1 more source